Pneumococcal Conjugate Vaccine impact assessment in Bangladesh

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gates Open Res
Autors principals: Baqui, Abdullah H., McCollum, Eric D., Saha, Samir K., Roy, Arun K., Chowdhury, Nabidul H., Harrison, Meagan, Hanif, Abu Abdullah Mohammad, Simmons, Nicole, Mahmud, Arif, Begum, Nazma, Ahmed, Salahuddin, Khan, Ahad M., Ahmed, Zabed Bin, Islam, Maksuda, Mitra, Dipak, Quaiyum, Abdul, Chavez, Miguel A., Pervaiz, Farhan, Miele, Catherine H., Schuh, Holly B., Khanam, Rasheda, Checkley, William, Moulton, Lawrence H., Santosham, Mathuram
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Limited 2018
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030398/
https://ncbi.nlm.nih.gov/pubmed/29984359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/gatesopenres.12805.1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars